Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. (Q43951673)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. |
scientific article |
Statements
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection (English)
Mohamed Rosmawati
Judy Lao
Hans Van Vlierberghe
Frank H Anderson
Neal Thomas
Deborah Dehertogh
1 December 2002